Esmael Habtamu1,2, Tariku Wondie2, Wubshet Gobezie2, Zerihun Tadesse2, Bizuayehu Gashaw3, Abebaw Gebeyehu3, Chrissy H Roberts1, E Kelly Callahan4, David Macleod5, Matthew J Burton1. 1. Clinical Research Department, International Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, United Kingdom. 2. The Carter Center, Addis Ababa, Ethiopia. 3. Amhara Regional Health Bureau, Bahirdar, Ethiopia. 4. The Carter Center, Georgia, Atlanta, United States of America. 5. Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Abstract
BACKGROUND: WHO endorsed the use of epilation as an alternative treatment to surgery for the management of both minor unoperated TT (UTT) and postoperative TT (PTT). However, some trachoma control programmes hesitated to implement epilation citing concerns that it would hamper TT surgical acceptance and result in larger numbers of and stiffer trichiatic eyelashes than the original TT lashes. We investigated the burden and phenotypes of post-epilation trichiatic eyelashes, and willingness to accept surgical management separately in unoperated and postoperative TT cases. METHODOLOGY/PRINCIPAL FINDINGS: We recruited cases with minor (≤5 eyelashes from the upper eyelid touching the eye or evidence of epilation in <1/3rd of the upper eyelid) UTT (170) and PTT (169) from community-based screenings in Amhara Region, Ethiopia. Participants eyes were examined and data on present and future willingness to accept surgical management collected at baseline and every month for 6-months. Eyelashes touching the eye were counted and their phenotypes documented. Participants were trained on how to epilate. Epilation was done by the participants at home and by the examiner during follow-ups when requested by the participant. Follow-up rates were ≥97%. There was evidence of a significant reduction in the burden of trichiatic eyelashes in unoperated (mean difference = -0.90 [-1.11- -0.69]; RR = 0.50 [95% CI, 0.40-0.62]; p<0.0001), and postoperative (mean difference = -1.16 [-1.36- -0.95]; RR = 0.38 [95% CI, 0.31-0.48]; p<0.0001) cases 6-month after frequent epilation. Post-epilation trichiatic eyelashes at 6-months had higher odds of being thin (40.2% vs 55.8%, OR = 1.88 [95% CI, 1.21-2.93]; p = 0.0048), weak (39.8% vs 70.8%, OR = 3.68 [95%CI,2.30-5.88]; p<0.0001), and half-length (30.9% vs 43.3%, OR = 1.71 [1.09-2.68]; p = 0.020) than the pre-epilation trichiatic eyelashes in unoperated cases. There was a significant increase in the proportion of weak trichiatic eyelashes (OR = 1.99 [95% CI, 1.03-3.83; p = 0.039) in postoperative cases. In all 6 follow-up time points, 120/164 (73.2%) of unoperated and 134/163 (82.2%) of postoperative cases indicated that they would accept surgery if their trichiasis progressed. CONCLUSIONS/SIGNIFICANCE: In this study setting, frequent epilation neither hampers surgical acceptance nor results in more damaging trichiatic eyelashes than the pre-epilation lashes; and can be used as an alternative to the programmatic management of minor unoperated and postoperative TT cases.
BACKGROUND: WHO endorsed the use of epilation as an alternative treatment to surgery for the management of both minor unoperated TT (UTT) and postoperative TT (PTT). However, some trachoma control programmes hesitated to implement epilation citing concerns that it would hamper TT surgical acceptance and result in larger numbers of and stiffer trichiatic eyelashes than the original TT lashes. We investigated the burden and phenotypes of post-epilation trichiatic eyelashes, and willingness to accept surgical management separately in unoperated and postoperative TT cases. METHODOLOGY/PRINCIPAL FINDINGS: We recruited cases with minor (≤5 eyelashes from the upper eyelid touching the eye or evidence of epilation in <1/3rd of the upper eyelid) UTT (170) and PTT (169) from community-based screenings in Amhara Region, Ethiopia. Participants eyes were examined and data on present and future willingness to accept surgical management collected at baseline and every month for 6-months. Eyelashes touching the eye were counted and their phenotypes documented. Participants were trained on how to epilate. Epilation was done by the participants at home and by the examiner during follow-ups when requested by the participant. Follow-up rates were ≥97%. There was evidence of a significant reduction in the burden of trichiatic eyelashes in unoperated (mean difference = -0.90 [-1.11- -0.69]; RR = 0.50 [95% CI, 0.40-0.62]; p<0.0001), and postoperative (mean difference = -1.16 [-1.36- -0.95]; RR = 0.38 [95% CI, 0.31-0.48]; p<0.0001) cases 6-month after frequent epilation. Post-epilation trichiatic eyelashes at 6-months had higher odds of being thin (40.2% vs 55.8%, OR = 1.88 [95% CI, 1.21-2.93]; p = 0.0048), weak (39.8% vs 70.8%, OR = 3.68 [95%CI,2.30-5.88]; p<0.0001), and half-length (30.9% vs 43.3%, OR = 1.71 [1.09-2.68]; p = 0.020) than the pre-epilation trichiatic eyelashes in unoperated cases. There was a significant increase in the proportion of weak trichiatic eyelashes (OR = 1.99 [95% CI, 1.03-3.83; p = 0.039) in postoperative cases. In all 6 follow-up time points, 120/164 (73.2%) of unoperated and 134/163 (82.2%) of postoperative cases indicated that they would accept surgery if their trichiasis progressed. CONCLUSIONS/SIGNIFICANCE: In this study setting, frequent epilation neither hampers surgical acceptance nor results in more damaging trichiatic eyelashes than the pre-epilation lashes; and can be used as an alternative to the programmatic management of minor unoperated and postoperative TT cases.
Authors: Stephanie L Palmer; Kate Winskell; Amy E Patterson; Kadri Boubacar; Fatahou Ibrahim; Ibrahim Namata; Tahirou Oungoila; Mohamed Salissou Kané; Adamou Sabo Hassan; Aryc W Mosher; Donald R Hopkins; Paul M Emerson Journal: Int Health Date: 2014-08-14 Impact factor: 2.473
Authors: Richard J C Bowman; Hannah Faal; Buba Jatta; Mark Myatt; Allen Foster; Gordon J Johnson; Robin L Bailey Journal: Invest Ophthalmol Vis Sci Date: 2002-04 Impact factor: 4.799
Authors: Emily W Gower; Sheila K West; Jennifer C Harding; Sandra D Cassard; Beatriz E Munoz; Majid S Othman; Amir B Kello; Shannath L Merbs Journal: JAMA Ophthalmol Date: 2013-03 Impact factor: 7.389
Authors: Saul N Rajak; Esmael Habtamu; Helen A Weiss; Amir Bedri Kello; Teshome Gebre; Asrat Genet; Robin L Bailey; David C W Mabey; Peng T Khaw; Clare E Gilbert; Paul M Emerson; Matthew J Burton Journal: PLoS Med Date: 2011-12-13 Impact factor: 11.069
Authors: Esmael Habtamu; Tariku Wondie; Sintayehu Aweke; Zerihun Tadesse; Mulat Zerihun; Bizuayehu Gashaw; Chrissy H Roberts; Amir Bedri Kello; David C W Mabey; Saul N Rajak; E Kelly Callahan; David Macleod; Helen A Weiss; Matthew J Burton Journal: Lancet Glob Health Date: 2018-05 Impact factor: 38.927
Authors: M J Burton; F Kinteh; O Jallow; A Sillah; M Bah; M Faye; E A N Aryee; U N Ikumapayi; N D E Alexander; R A Adegbola; H Faal; D C W Mabey; A Foster; G J Johnson; R L Bailey Journal: Br J Ophthalmol Date: 2005-10 Impact factor: 4.638
Authors: Esmael Habtamu; Tariku Wondie; Sintayehu Aweke; Zerihun Tadesse; Mulat Zerihun; Zebideru Zewudie; Wondimu Gebeyehu; Kelly Callahan; Paul M Emerson; Hannah Kuper; Robin L Bailey; David C W Mabey; Saul N Rajak; Sarah Polack; Helen A Weiss; Matthew J Burton Journal: PLoS Negl Trop Dis Date: 2015-11-23
Authors: Anthony W Solomon; Matthew J Burton; Emily W Gower; Emma M Harding-Esch; Catherine E Oldenburg; Hugh R Taylor; Lamine Traoré Journal: Nat Rev Dis Primers Date: 2022-05-26 Impact factor: 52.329
Authors: Riju Shrestha; Shannath L Merbs; Belay Bayissasse; Alemayehu Sisay; Colin Beckwith; Paul Courtright; Emily W Gower Journal: Int Health Date: 2022-04-06 Impact factor: 3.131